Western Illinois Trial Site Organization First to Enroll Patient in Global Clinical Trial Investigating New Drugs Targeting Advanced Kidney Cancer

Western Illinois Trial Site Organization First to Enroll Patient in Global Clinical Trial Investigating New Drugs Targeting Advanced Kidney Cancer

A trial site based in Illinois demonstrated recruitment competitive savvy, recently positioning publicly that they were the first such location to enroll patients for two prominent cancer-focused clinical trials sponsored by Merck. Illinois CancerCare actually represents one of the largest private oncology and hematology practices not only in this Midwestern state but also across America. Presently with 14 clinics, the organization positions itself as one of the first to introduce clinical research as a care option to oncology patients, that is, to bring physicians, nurses, and state-of-the-art cancer treatments to patients right in their hometown communities, declares Principal Investigator Dr. Gary R. MacVicar. Recently, the oncology and hematology-focused cancer care and research operation announced not only participation in two Merck-sponsored trials, one addressing kidney cancer with the other focusing on lung cancer—but also that their various trial sites produced the first patients in the two industry-sponsored studies.

Local media WFMZ 69 News reported on this research organization’s activities, which TrialSite discovered were two of at least 24 studies the trial site’s...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee